Makary Resigns as FDA Commissioner Following Policy Disputes
Conexiant
May 12, 2026
Marty Makary resigned as FDA Commissioner after 13 months, with Kyle Diamantas appointed as acting commissioner.
Makary's tenure included workforce reductions and significant turnover among senior FDA officials.
He opposed pediatric mask and vaccine mandates during the COVID-19 pandemic, criticizing CDC data reliance.
Makary focused on vaccine policy, food additive regulation, and dietary guidance, advocating for reduced processed food intake.
His resignation followed tensions over telehealth prescribing, regulatory review consistency, and flavored vaping product authorizations.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Editor
Affiliations:
Specialties:
Areas of Expertise: